Login

Sandro Tobler, VP of Fiber Optic Technology and Operations, shares his experience working at HUBER+SUHNER. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Reviewing Hg Capital Trust's Strong Performance Under Chairman Jim Strang | Jim Strang, CHAIRMAN, Hg Capital Trust plc.
00:10:00
investing from the earliest seeds of startup life to businesses scaling for growth|Ben Savage,Partner,Clocktower Technology Ventures
00:10:00
How Should We Treat the Bad Guys?|Jenny Martinez
00:10:00
Franco-Nevada Australia: Leading in Royalties and Streams
00:10:00
partner for developer first SaaS & crypto infrastructure founders|Shomik Ghosh,Partner,Boldstart Ventures
00:10:00
OrbiMed is considered to be one of the largest dedicated healthcare investment firms in the world|Trevor, Portfolio Manager,OrbiMed Advisors
00:10:00
Scott Thompson Appointed as Scotiabank's New CEO: A Vision for Growth and Transformation | Scott Thompson, CEO, Scotiabank.
00:10:00
Exploring Aerospace's Future: Hanwha Aerospace CEO Shares Vision | Jae-il Son, CEO and President of Hanwha Aerospace
00:10:00
Pioneering Drug Development for Inflammation and Cancer | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Inside the Mind of Emmanuel Roman: PIMCO's Visionary Leader on Fixed Income, AI, and Market Opportunities|  Emmanuel Roman, CEO, PIMCO.
00:10:00
Positive Financial Results Signal Growth Potential| David Klein, CEO, Canopy Growth Corp.
00:10:00
CEO Chip Paucek on the Company’s 257% Surge and Strategic University Partnerships | Chip Paucek, CEO , 2U Inc.

© 2026 Nehu